News & Updates

Obesity influences link between dietary calcium intake, CVD risk

07 Jun 2020

Obesity status appears to mediate the relationship between dietary calcium and incident cardiovascular disease (CVD), suggests a Korean study.

Obesity influences link between dietary calcium intake, CVD risk

07 Jun 2020

Primary CV prevention with aspirin may be more harmful than beneficial in diabetics

05 Jun 2020

Using aspirin for the primary prevention of cardiovascular (CV) diseases appears to confer increased harm and lack of survival benefit, yielding a modest decrease in major adverse CV events but a concomitant elevation in major bleeding, according to a study.

Primary CV prevention with aspirin may be more harmful than beneficial in diabetics

05 Jun 2020

Diabetes affects weight loss magnitude after bariatric surgery

04 Jun 2020 by

The magnitude of weight loss following bariatric surgery for obesity may be reduced among individuals who have diabetes prior to surgery, according to a retrospective study presented at ENDO 2020.

Diabetes affects weight loss magnitude after bariatric surgery

04 Jun 2020

Maternal BMI, glycaemia linked to childhood adiposity

04 Jun 2020

Midpregnancy maternal body mass index (BMI) and glycaemia show an independent and additive association with direct adiposity measures in children aged 10–14 years, suggests a study. The combination of maternal obesity and gestational diabetes mellitus (GDM) correlates with the highest risk of childhood adiposity.

Maternal BMI, glycaemia linked to childhood adiposity

04 Jun 2020

Metformin counters risks associated with diabetes in NASH cirrhosis patients

04 Jun 2020 by

Type 2 diabetes mellitus (T2DM) contributes to a heightened risk of death, hepatic decompensation, and hepatocellular carcinoma (HCC) among patients with nonalcoholic steatohepatitis (NASH) and cirrhosis, but the good news is that metformin may cut the risk of these adverse outcomes, a study has found.

Metformin counters risks associated with diabetes in NASH cirrhosis patients

04 Jun 2020

HbA1c grading tied to drug resistance in TB patients with T2DM

04 Jun 2020

HbA1c grading influences the risk of developing isoniazid resistance and multidrug resistance (MDR) in tuberculosis (TB) infected patients with type 2 diabetes mellitus (T2DM), a study suggests.

HbA1c grading tied to drug resistance in TB patients with T2DM

04 Jun 2020

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

03 Jun 2020 by

Once-daily 14 mg oral semaglutide yields greater reduction in HbA1c and body weight than weekly 0.75 mg subcutaneous dulaglutide and is well tolerated in a Japanese population with uncontrolled type 2 diabetes (T2D), according to the PIONEER 10 study.

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

03 Jun 2020

Psychiatric comorbidities frequent among transgender teens

03 Jun 2020 by

There is a high incidence of psychiatric comorbidities among gender nonconforming teenagers, with about two-thirds and one-third experiencing depression and anxiety, respectively, according to a study presented at ENDO 2020.

Psychiatric comorbidities frequent among transgender teens

03 Jun 2020

Long-term radioiodine treatment effective in toxic multinodular goiter

03 Jun 2020

Treatment with 15 mCi of radioiodine (RAI) leads to low hypothyroidism rates in adult patients with toxic multinodular goiter (TMNG), with high cure rates and significant volume reduction, according to a study. This effect persists in the long term.

Long-term radioiodine treatment effective in toxic multinodular goiter

03 Jun 2020

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

03 Jun 2020

The glucagon-like peptide-1 (GLP-1) receptor agonist (RA) dulaglutide shows highly consistent effectiveness on glycated haemoglobin (HbA1c) and body weight reduction in patients with type 2 diabetes (T2D), reveals a study. Its effectiveness remains significant even in subgroups of patients poorly represented in randomized controlled trials (RCTs).

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

03 Jun 2020

News & Updates

Filter by Specialty:

Specialty:

Obesity influences link between dietary calcium intake, CVD risk

Obesity influences link between dietary calcium intake, CVD risk

Primary CV prevention with aspirin may be more harmful than beneficial in diabetics

Primary CV prevention with aspirin may be more harmful than beneficial in diabetics

Diabetes affects weight loss magnitude after bariatric surgery

Diabetes affects weight loss magnitude after bariatric surgery

Maternal BMI, glycaemia linked to childhood adiposity

Maternal BMI, glycaemia linked to childhood adiposity

Metformin counters risks associated with diabetes in NASH cirrhosis patients

Metformin counters risks associated with diabetes in NASH cirrhosis patients

HbA1c grading tied to drug resistance in TB patients with T2DM

HbA1c grading tied to drug resistance in TB patients with T2DM

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

Psychiatric comorbidities frequent among transgender teens

Psychiatric comorbidities frequent among transgender teens

Long-term radioiodine treatment effective in toxic multinodular goiter

Long-term radioiodine treatment effective in toxic multinodular goiter

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients